Atlas Capital Advisors’s Array Biopharma Inc ARRY Stock Holding History

Atlas Capital Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-13,866	Closed	-$642K	–	716
2019 Q2	$642K	Buy	+13,866	New	+$389K	0.21%	133

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Atlas Capital Advisors's ARRY Position: Q3 2019 in Review

Atlas Capital Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 13,866 shares — an estimated $642K sold.

Atlas Capital Advisors first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $642K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Atlas Capital Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Atlas Capital Advisors sold 13,866 Array Biopharma Inc shares in Q3 2019, an estimated $642K.
Atlas Capital Advisors first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Atlas Capital Advisors's Array Biopharma Inc position peaked at $642K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Atlas Capital Advisors's 13F filing for Q3 2019, filed 1 Nov 2019.